Journal Mobile Options
Table of Contents
Vol. 13, No. 2, 2007
Issue release date: March 2007
Eur Addict Res 2007;13:109–115
(DOI:10.1159/000097941)

Anxiety Disorders: Treatable regardless of the Severity of Comorbid Alcohol Dependence

Schadé A. · Marquenie L.A. · van Balkom A.J.L.M. · Koeter M.W.J. · de Beurs E. · van Dyck R. · van den Brink W.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Aims: Clinical and epidemiological research has shown that comorbidity is the rule rather than exception in the case of psychiatric disorders. Cognitive behavioral therapy (CBT) has been clearly demonstrated to be effective in treating anxiety and avoidance symptoms in patient samples of social phobia and agoraphobia without comorbid alcohol use disorders. It has recently been shown that treatment of comorbid anxiety disorders in alcohol-dependent patients can also be very successful. The purpose of the present study was to find predictors of treatment success for comorbid anxiety disorders in alcohol-dependent patients. Methods: The study was conducted in a sample of 34 completers with a double diagnosis of alcohol dependence and agoraphobia or social phobia who received CBT for their comorbid anxiety disorder in a 32-week randomized controlled trial comparing alcohol and CBT anxiety disorder treatment with alcohol treatment alone. In the current report, treatment success was defined as a clinically significant change (recovery) on the anxiety discomfort scale. Results: The severity of comorbid alcohol dependence did not influence the beneficial effect of CBT on the anxiety disorder. Psychological distress (SCL-90), neuroticism (NEO N), conscientiousness (NEO C), gender, employment and age of onset of alcohol dependence showed some predictive value. Conclusions: Alcohol-dependent males with a comorbid anxiety disorder seem to benefit most from CBT if their alcohol dependence started after age 25, if they are employed and if their general psychopathology is less severe. The most important conclusion, however, is that even severely alcohol-dependent patients with an anxiety disorder can benefit from psychotherapy for their anxiety disorder.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19.
  2. Ravelli A, Bijl R, van Zessen G: Comorbiditeit van psychiatrische stoornissen in de Nederlandse bevolking; resultaten van de Netherlands Mental Health Survey and Incidence Study (NEMESIS). Tijdschr Psychiatrie 1998;40:531–544.
  3. Kushner MG, Abrams K, Borchardt C: The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 2000;20:149–171.
  4. Schneider U, Altmann A, BaumannM, et al: Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany. Alcohol Alcohol 2001;3:219–223.
  5. Gould RA, Otto MW, Pollack MF: A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995;8:819–844.

    External Resources

  6. Chambless DL, Tran GQ, Glass CR: Predictors of response to cognitive-behavioral group therapy for social phobia. J Anxiety Disord 1997;11:221–240.
  7. van Balkom AJ, Bakker A, Spinhoven P, Blaauw BM, Smeenk S, Ruesink B: A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 1997;185:510–516.
  8. Oosterbaan DB, van Balkom AJ, Spinhoven P, Oppen P, van Dyck R: Cognitive therapy versus moclobemide in social phobia: a controlled study. J Clin Psychol Psychother 2001;8:263–273.

    External Resources

  9. Taylor S: Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry 1996;27:1–9.
  10. Schadé A, Marquenie LA, van Balkom AJ, Koeter MWJ, de Beurs E, van den Brink W, van Dyck R: The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcohol Clin Exp Res 2005;5:794–800.

    External Resources

  11. Steketee GS, Chambless DL: Methodological issues in prediction of treatment outcome. Clin Psychol Rev 1992;12: 387–400.

    External Resources

  12. Grant BF: DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse/harmful use and dependence, United States, 1992: a nosological comparison. Alcohol Clin Exp Res 1996;20:1481–1488.
  13. Balkom van AJ, Oosterbaan DD, Duyck van R: Benzodiazepines as pharmacotherapeutic possibility in the treatment of panic disorders. Ned Tijdschr Geneeskd 1992;29:410–413.
  14. Beurs de E, Lange A, van Dyck R, Koele P: Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome. Aust NZ J Psychiatry 1995;29:104–113.
  15. Slaap BR, den Boer JA: The prediction of nonresponse to pharmacotherapy in panic disorder: a review. Depress Anxiety 2001;14:112–122.
  16. Slaap BR, Vliet van IM, Westenberg HG, Den Boer, JA: Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response. J Affect Disord 1996;20:13–19.

    External Resources

  17. Scholing A, Emmelkamp PM: Prediction of treatment outcome in social phobia: a cross-validation. Behav Res Ther 1999;37:659–670.
  18. Versiani M, Amrein R, Montgomery SA: Social phobia: long-term treatment outcome and prediction of response. A moclobemide study. Int Clin Psychopharmacol 1997;12:239–254.
  19. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K: The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 2001;36:249–255.
  20. Schuckit MA, Monteiro MG: Alcoholism, anxiety and depression. Br J Addict 1988;83:1373–1380.
  21. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis Disorders SCID-1/P (version 2.0). New York, Biometrics Research Department, 1996.
  22. Kokkevi A, Hartgers C: EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 1995;1:208–210.

    External Resources

  23. Beck AT, Emery G: Anxiety Disorders and Phobias: A Cognitive Perspective.New York, Basic Books, 1985.
  24. Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12–19.
  25. Emmelkamp PM, Kraaijkamp HJ, van den Hout MA: Assessment of obsessive-compulsive disorder. Behav Modif 1999;23:269–279.
  26. Derogatis IR: SCL-90: Administration, Scoring and Procedures Manual-I for the R(evised) Version. Baltimore, John Hopkins University School of Medicine, 1997.
  27. Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther 1997;17:263–267.

    External Resources

  28. Watson JP, Marks IM: Relevant and irrelevant fear in flooding: a crossover study of phobic patients. Behav Ther 1971;2:275–293.

    External Resources

  29. Beck AT, Steer RA Beck: Depression Inventory. San Antonio, Psychological Corporation, 1987.
  30. Costa PT, McCrae RR: The NEO Personality Inventory Manual. Odessa, Psychological AssessmentResources, 1985.
  31. Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism.Science 1987;236:410–416.
  32. Cloninger CR, Sigvardsson S, Bohman M: Childhood personality predicts alcohol abuse in young adults. Alcohol Clin Exp Res 1988;12:494–505.
  33. Irwin M, Schuckit M, Smith TL: Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch Gen Psychiatry 1990;47:320–324.
  34. von Knorring L, von Knorring AL, Smigan L, Lindberg U, Edholm M: Personality traits in subtypes of alcoholics. J Stud Alcohol 1987;48:523–527.
  35. Thase ME, Reynolds CF, Simons FE, McGeary J, Fasiczka AL, Garamoni GG, Jennings JR, Kupfer DJ: Do depressed men and women respond similarly to cognitive behavior therapy? Am J Psychiatry 1994;151:500–505.
  36. Frank E, Carpenter LL, Kupfer D: Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry 1988;145:41–45.
  37. Kornstein SG: Chronic depression in women J Clin Psychiatry 2002;63:602–609.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50